Antirheumatic agent
AssigneeKyoto Pharmaceutical Industries, Ltd.
InventorsHiroaki Shirahase, Akihisa Yoshimi, Fumio Fukata, Hideki Okunishi, Yuta Kobayashi
Life of this patent
Estimating the term…
Abstract
An antirheumatic agent comprising diethyl L-lysylcromoglycate of the following formula ##STR1## or a nontoxic salt thereof as an active ingredient. This compound has an anti-inflammatory action and immunomodulating action, is absorbed by oral administration to be delivered efficiently to local sites, and is associated with fewer side effects, so that it serves well as an antirheumatic agent that can be administered orally.
Claims6
A method of treating rheumatism, comprising administering an effective amount of diethyl L-lysylcromoglycate or a nontoxic salt thereof to a patient.
A method of treating rheumatism, comprising administering a pharmaceutical composition to a patient, wherein the pharmaceutical composition comprises diethyl L-lysylcromoglycate or a nontoxic salt thereof and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.